Health FDA Grants Approval for Sanofi’s Key BTK Inhibitor The U.S. Food and Drug Administration (FDA) has granted approval for Sanofi’s BTK inhibitor, a significant component of the company’s immunology strategy. This development... Editorial6 hours ago